Home   Categories   Grid

Subscribe Now

The microbiome, human faecal transplants and the impact of everyday products on our health

The microbiome, human faecal transplants and the impact of everyday products on our health

The microbiome, human faecal transplants and the impact of everyday products on our health

16 February 2019

We share our bodies with trillions of micro-organisms - and Eagle Genomics is using AI to help us understand what's happening to them


Billion Pound insights into scaling a business

Billion Pound insights into scaling a business

Billion Pound insights into scaling a business

09 February 2019

Stellar panel at the Bradfield Centre for Cambridge Start-up Billion Pound Scale Up Challenge


Matt Forde: finding the humour in Brexit

Matt Forde: finding the humour in Brexit

Matt Forde: finding the humour in Brexit

01 February 2019

Following a sold-out and run at the Edinburgh Festival Fringe, star of Unspun Matt Forde is embarking on a nationwide tour


How AI company IntelliSense.io is transforming the mining industry from Cambridge

How AI company IntelliSense.io is transforming the mining industry from Cambridge

How AI company IntelliSense.io is transforming the mining industry from Cambridge

31 January 2019

CEO Sam Bose explains how it's improving mining operations from Kazakhstan to Chile


AstraZeneca's new Cambridge HQ will be a 'phenomenal' place to work says Dr Mene Pangalos

AstraZeneca's new Cambridge HQ will be a 'phenomenal' place to work says Dr Mene Pangalos

AstraZeneca's new Cambridge HQ will be a 'phenomenal' place to work says Dr Mene Pangalos

25 January 2019

'Open, porous, collaborative' place will help bolster UK life sciences, says senior executive


£1.1m funding helps CamBioScience turn e-learning into AI-learning

£1.1m funding helps CamBioScience turn e-learning into AI-learning

£1.1m funding helps CamBioScience turn e-learning into AI-learning

19 January 2019

An interview with CEO Dr Chibeza Agley as Cambridge company secures investment for its OBRIZUM platform


2019 Rising Festival speaker Loveness Mangezi shares her story

2019 Rising Festival speaker Loveness Mangezi shares her story

2019 Rising Festival speaker Loveness Mangezi shares her story

12 January 2019

Ahead of the 2019 Rising Festival – a day of talks and workshops designed to help women realise their potential, Alice Ryan meets two of the speakers.


How AstraZeneca achieved a fivefold increase in its new medicines success rate

How AstraZeneca achieved a fivefold increase in its new medicines success rate

How AstraZeneca achieved a fivefold increase in its new medicines success rate

09 January 2019

Dr Mene Panaglos explains how a change in culture led to dramatic results for the pharmaceutical company


Chief scientist at AstraZeneca tells of huge potential of partnership with Cancer Research UK

Chief scientist at AstraZeneca tells of huge potential of partnership with Cancer Research UK

Chief scientist at AstraZeneca tells of huge potential of partnership with Cancer Research UK

30 December 2018

The biopharmaceutical company is teaming up with CRUK on a Functional Genomics Centre in Cambridge


Gerald Ratner to speak at Institute of Directors Cambridgeshire dinner 2018

Gerald Ratner to speak at Institute of Directors Cambridgeshire dinner 2018

Gerald Ratner to speak at Institute of Directors Cambridgeshire dinner 2018

18 August 2018

Jeweller will tell of astonishing rise, fall and rise again - and those ill-advised remarks to IoD in 1991


Proteins and the machinery of life

Proteins and the machinery of life

Proteins and the machinery of life

01 June 2018

Fluidic Analytics’s technology speeds up lab work – and is heading for the consumer care sector


Visual effects firm Vine FX is pure magic

Visual effects firm Vine FX is pure magic

Visual effects firm Vine FX is pure magic

20 April 2018

How DO they do that? From Patrick Melrose to Atlantis and Troy, the Cambridge studio has the answers?


Martin Bell to talk at Cambridgeshire Institute of Directors' annual dinner in Cambridge

Martin Bell to talk at Cambridgeshire Institute of Directors' annual dinner in Cambridge

Martin Bell to talk at Cambridgeshire Institute of Directors' annual dinner in Cambridge

09 August 2017

The IoD will hold its prestigious event at St John's College.


Get on board for the Cambridge Independent Entrepreneurial Science and Technology Awards

Get on board for the Cambridge Independent Entrepreneurial Science and Technology Awards

Get on board for the Cambridge Independent Entrepreneurial Science and Technology Awards

12 May 2017

Global networks support our initiative for start-ups and scale-ups


Why Brexit represents a challenge and opportunity

Why Brexit represents a challenge and opportunity

Why Brexit represents a challenge and opportunity

14 October 2016

David Newble, managing director of TTP Labtech, gives his view on what the EU referendum result means for business.


The big changes in Cambridge's £2 billion tourism industry

The big changes in Cambridge's £2 billion tourism industry

The big changes in Cambridge's £2 billion tourism industry

08 October 2016

Visit Cambridge and Beyond CEO's call to arms


Charles Cotton on The Cambridge Phenomenon and the next 50 years

Charles Cotton on The Cambridge Phenomenon and the next 50 years

Charles Cotton on The Cambridge Phenomenon and the next 50 years

19 September 2016

The man behind the Cambridge Phenomenon says the city has ‘stickability’ - and predicts a bright, innovative future.


Talking parrots: hatching ideas from Lord Ashcroft Business School

Talking parrots: hatching ideas from Lord Ashcroft Business School

Talking parrots: hatching ideas from Lord Ashcroft Business School

19 September 2016

Anglia Ruskin student's IoD committee post brings unexpected business opportunity.


David Chiswell on how he hopes to build Cambridge biotech firm Kymab into $40bn global success story

David Chiswell on how he hopes to build Cambridge biotech firm Kymab into $40bn global success story

David Chiswell on how he hopes to build Cambridge biotech firm Kymab into $40bn global success story

28 July 2016

He built Cambridge Antibody Technology from scratch and sold it for $1.32bn: now David Chiswell is thinking bigger - much bigger.


This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies - Learn More